1-3 of 3
Chong Chyn Chua
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia

Fiona C Brown, Xin Wang, Richard W Birkinshaw, Chong Chyn Chua, Thomas David Morley, Sila Kasapgil, Giovanna Pomilio, Piers Blombery, David Ching Siang Huang, Professor, Peter E Czabotar, Salvatore F Priore, Guang Yang, Martin P. Carroll, Andrew H. Wei, Alexander E. Perl
Journal: Blood Advances
Blood Adv bloodadvances.2024014446.
https://doi.org/10.1182/bloodadvances.2024014446
Published: 2024
Includes: Supplemental data
Journal Articles

Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells

Clinical Trials & Observations
Charis E. Teh, Hongke Peng, Meng-Xiao Luo, Tania Tan, Marie Trussart, Lauren J. Howson, Chong Chyn Chua, Christine Muttiah, Fiona Brown, Matthew E. Ritchie, Andrew H. Wei, Andrew W. Roberts, Vanessa L. Bryant, Mary Ann Anderson, Geoffrey J. Lindeman, David C. S. Huang, Rachel Thijssen, Daniel H. D. Gray
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2733–2745.
https://doi.org/10.1182/bloodadvances.2022008221
Published: 2023
Includes: Supplemental data
Journal Articles

Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia

Chong Chyn Chua, Danielle Hammond, Andrew Kent, Ing Soo Tiong, Marina Y. Konopleva, Daniel A. Pollyea, Courtney D. DiNardo, Andrew H. Wei
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3879–3883.
https://doi.org/10.1182/bloodadvances.2022007083
Published: 2022
Includes: Supplemental data